The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer (Q34600965)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer |
scientific article |
Statements
1 reference
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer (English)
1 reference
Laurence Klotz
1 reference
Laurent Boccon-Gibod
1 reference
Neal D Shore
1 reference
Cal Andreou
1 reference
Bo-Eric Persson
1 reference
Per Cantor
1 reference
Jens-Kristian Jensen
1 reference
Tine Kold Olesen
1 reference
Fritz H Schröder
1 reference
1 December 2008
1 reference
1 reference
102
1 reference
11
1 reference
1531-1538
1 reference
Identifiers
1 reference
1 reference